The BC-BM pair ratios of CD86+ M1 to CD163+ M2 macrophages and CD86+ M1 to CD206+ M2 macrophages were also significantly higher in primary BC than in BCBM (p = 0.005 and p = 0.008, respectively) (Figure 4d). Here, CD163 is linked to breast cancer.